{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T12:19:10Z","timestamp":1759580350566},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T00:00:00Z","timestamp":1329177600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0030567","type":"journal-article","created":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T22:03:47Z","timestamp":1329257027000},"page":"e30567","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nilotinib and Imatinib Are Comparably Effective in Reducing Growth of Human Eosinophil Leukemia Cells in a Newly Established Xenograft Model"],"prefix":"10.1371","volume":"7","author":[{"given":"Daniel","family":"Wicklein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuno","family":"Ramos Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Salamon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Thamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Valent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Ullrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,2,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.blre.2009.01.001","article-title":"Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders.","volume":"23","author":"P Valent","year":"2009","journal-title":"Blood Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1750-1172-2-37","article-title":"Hypereosinophilic syndromes.","volume":"2","author":"FE Roufosse","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaci.2010.03.035","article-title":"Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence.","volume":"126","author":"MM Crane","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bbrc.2007.12.063","article-title":"Mechanisms for the proliferation of eosinophilic leukemia cells by FIP1L1-PDGFRalpha.","volume":"366","author":"K Ishihara","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaci.2010.03.042","article-title":"Refining the definition of hypereosinophilic syndrome.","volume":"126","author":"HU Simon","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4065\/mcp.2009.0503","article-title":"Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update.","volume":"85","author":"A Tefferi","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.","volume":"348","author":"J Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood.V66.6.1233.1233","article-title":"Establishment and characterization of a new human eosinophilic leukemia cell line.","volume":"66","author":"H Saito","year":"1985","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2141.2008.07033.x","article-title":"A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1-PDGFRA-expressing patients.","volume":"141","author":"G Helbig","year":"2008","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1182\/blood-2003-07-2479","article-title":"The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia.","volume":"103","author":"J Cools","year":"2004","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1182\/blood-2007-06-098079","article-title":"Ki11502, a novel multitargeted receptor tyrosine kinase inhibitor, induces growth arrest and apoptosis of human leukemia cells in vitro and in vivo.","volume":"111","author":"C Nishioka","year":"2008","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.leukres.2005.03.019","article-title":"Transplantation of human acute myeloid leukemia (AML) cells in immunodeficient mice reveals altered cell surface phenotypes and expression of human endothelial markers.","volume":"29","author":"R Henschler","year":"2005","journal-title":"Leuk Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1054\/bjoc.2000.1565","article-title":"Anti-CD7 antibody and immunotoxin treatment of human CD7(+)T-cell leukaemia is significantly less effective in NOD\/LtSz-scid mice than in CB.17 scid mice.","volume":"83","author":"DJ Flavell","year":"2000","journal-title":"Br J Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.1016\/j.bmc.2010.08.026","article-title":"Structural resemblances and comparisons of the relative pharmacological properties of imatinib and nilotinib.","volume":"18","author":"PW Manley","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1182\/blood-2007-02-073700","article-title":"AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo.","volume":"110","author":"J Yang","year":"2007","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/j.leukres.2010.02.024","article-title":"Successful treatment of imatinib-resistant hypereosinophilic syndrome with nilotinib.","volume":"34","author":"T Ikezoe","year":"2010","journal-title":"Leuk Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/leu.2009.2","article-title":"FIP1L1-PDGFRalpha D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRalpha T674I eosinophilic leukemia with single agent sorafenib.","volume":"23","author":"E Lierman","year":"2009","journal-title":"Leukemia"},{"key":"ref18","article-title":"Low-dose Nilotinib can maintain complete molecular remissions in FIP1L1\/PDGFRA-positive hypereosinophilic syndrome.","author":"E Tabouret","year":"2010","journal-title":"Leuk Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/hon.919","article-title":"Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1-PDGFRA fusion transcript\u2013results of Polish multicentre study.","volume":"28","author":"G Helbig","year":"2009","journal-title":"Hematol Oncol"},{"key":"ref20","first-page":"198","article-title":"Normal mouse erythropoiesis. I. The role of the spleen in mouse erythropoiesis.","volume":"26","author":"I Brodsky","year":"1966","journal-title":"Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S0046-8177(99)90149-1","article-title":"The role of trisomy 8 in the pathogenesis of chronic eosinophilic leukemia.","volume":"30","author":"SK Ma","year":"1999","journal-title":"Hum Pathol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1080\/10428190600967196","article-title":"Granulocytic sarcoma: 32 cases and review of the literature.","volume":"47","author":"S Paydas","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0002-9440(10)63052-0","article-title":"Granulocytic sarcoma in MLL-positive infant acute myelogenous leukemia: fluorescence in situ hybridization study of childhood acute myelogenous leukemia for detecting MLL rearrangement.","volume":"159","author":"KU Park","year":"2001","journal-title":"Am J Pathol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/leu.2008.287","article-title":"Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias.","volume":"22","author":"J Gotlib","year":"2008","journal-title":"Leukemia"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2141.2008.07294.x","article-title":"Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome: a phase-II study.","volume":"143","author":"G Metzgeroth","year":"2008","journal-title":"Br J Haematol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/sj.bjc.6605642","article-title":"Guidelines for the welfare and use of animals in cancer research.","volume":"102","author":"P Workman","year":"2010","journal-title":"Br J Cancer"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/sj.bjc.6603594","article-title":"Clinically proven markers of metastasis predict metastatic spread of human melanoma cells engrafted in scid mice.","volume":"96","author":"A Thies","year":"2007","journal-title":"Br J Cancer"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0030567","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T18:38:31Z","timestamp":1713551911000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0030567"}},"subtitle":[],"editor":[{"given":"Kevin D.","family":"Bunting","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,2,14]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,2,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0030567","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,14]]}}}